Amyris, Inc. (AMRS)

NASDAQ: AMRS · IEX Real-Time Price · USD
1.59
+0.06 (3.92%)
At close: Jan 31, 2023, 4:00 PM
1.58
-0.01 (-0.63%)
Pre-market: Feb 1, 2023, 8:10 AM EST
3.92%
Market Cap 577.95M
Revenue (ttm) 258.82M
Net Income (ttm) -341.15M
Shares Out 363.49M
EPS (ttm) -1.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,110
Open 1.55
Previous Close 1.53
Day's Range 1.52 - 1.59
52-Week Range 1.25 - 5.31
Beta 1.04
Analysts Buy
Price Target 7.16 (+350.31%)
Earnings Date Mar 7, 2023

About AMRS

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company ... [Read more]

Sector Materials
IPO Date Sep 28, 2010
Employees 980
Stock Exchange NASDAQ
Ticker Symbol AMRS
Full Company Profile

Financial Performance

In 2021, Amyris's revenue was $341.82 million, an increase of 97.43% compared to the previous year's $173.14 million. Losses were -$270.46 million, -29.26% less than in 2020.

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for AMRS stock is "Buy." The 12-month stock price forecast is $7.16, which is an increase of 350.31% from the latest price.

Price Target
$7.16
(350.31% upside)
Analyst Consensus: Buy
Stock Forecasts

News

AMYRIS LAUNCHES 4U BY TIA™ HAIRCARE LINE EXCLUSIVELY AT WALMART

EMERYVILLE, Calif. , Jan. 30, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

2 days ago - PRNewsWire

AMYRIS TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTH CARE CONFERENCE

EMERYVILLE, Calif. , Jan. 4, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

1 month ago - PRNewsWire

AMYRIS ANNOUNCES $50 MILLION REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT

EMERYVILLE, Calif. , Dec. 29, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

1 month ago - PRNewsWire

AMYRIS SUCCESSFULLY ADVANCES STRATEGIC TRANSACTION

EMERYVILLE, Calif., Dec. 27, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

1 month ago - PRNewsWire

AMYRIS CONSUMER BRANDS DELIVER 80% CYBER MONDAY LIKE-FOR-LIKE GROWTH

EMERYVILLE, Calif. , Nov. 30, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

2 months ago - PRNewsWire

Amyris, Inc. (AMRS) Reports Q3 Loss, Misses Revenue Estimates

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -109.52% and 36.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

AMYRIS, INC. REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

Sixth consecutive quarter of record consumer revenue – Consumer revenue of $46.6 million increased 98% compared to Q3 2021 Record core revenue of $71.1 million grew 49% compared to the prior year quar...

3 months ago - PRNewsWire

7 Cheap Penny Stocks to Buy Before They Pop Off

It may seem a little crazy to talk about finding cheap penny stocks to buy at this time. The economy is cooling, and even blue-chip stocks are struggling to gain traction.

Other symbols: BNGOCGCFCELHOFVMMATBTG
3 months ago - InvestorPlace

AMYRIS TO HOST THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 8

EMERYVILLE, Calif. , Nov. 1, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

3 months ago - PRNewsWire

Amyris and World Wildlife Fund Announce Partnership to Protect Biodiversity

EMERYVILLE, Calif. , Oct. 25, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

3 months ago - PRNewsWire

AMYRIS SUCCESSFULLY LAUNCHES TWO NEW CONSUMER BRANDS

EMERYVILLE, Calif. , Oct. 24, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

3 months ago - PRNewsWire

Amyris Brands Expanding in UK and Europe. Executing on continued accelerated growth and lower costs

EMERYVILLE, Calif. , Oct. 11, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

4 months ago - PRNewsWire

Will Synthetic Biology Firm Amyris Post Net Income In 2024?

Synthetic biology maker Amyris owns a 60% global market share for a product that's increasingly used in personal care products. Will it notch a profit in 2024?

4 months ago - MarketBeat

AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES

EMERYVILLE, Calif. , Sept. 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

5 months ago - PRNewsWire

AMYRIS PUBLISHES SECOND ANNUAL ESG REPORT

EMERYVILLE, Calif. , Aug. 31, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

5 months ago - PRNewsWire

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Amyris, Inc.

Wilmington, Delaware--(Newsfile Corp. - August 9, 2022) - Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Amyris, Inc. (NASDAQ: AMRS) on behalf of stockhold...

6 months ago - Newsfile Corp

Amyris, Inc. (AMRS) Reports Q2 Loss, Lags Revenue Estimates

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -50% and 20.06%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

AMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS

Record consumer revenue of $43 million increased 108% compared to Q2 2021 Ingredients sold out in first half with $15 million backlog to be supplied in H2 Cost actions and price increases to deliver $...

6 months ago - PRNewsWire

AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT

EMERYVILLE, Calif. , Aug. 3, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

6 months ago - PRNewsWire

AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9

EMERYVILLE, Calif. , July 28, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

6 months ago - PRNewsWire

AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION

EMERYVILLE, Calif. , June 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab...

7 months ago - PRNewsWire

AMYRIS TO PARTICIPATE AT THE OPPENHEIMER 22nd ANNUAL CONSUMER CONFERENCE

EMERYVILLE, Calif. , June 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

8 months ago - PRNewsWire

AMYRIS PARTICIPATES IN INVESTOR CONFERENCES ON MAY 23, 24 AND 25, 2022

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

9 months ago - PRNewsWire

AMYRIS TO PARTICIPATE AT MAY INVESTOR CONFERENCES

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-...

9 months ago - PRNewsWire

Amyris (AMRS) Earnings and Revenues Lag Estimates in Q1

Amyris (AMRS) sees strong revenues in its consumer segment in Q1 driven by growth of its legacy brands and strong contribution from new brands.

9 months ago - Zacks Investment Research